Explainer for COVAX Allocation Phase 2

Overview

Given the pandemic's evolution and COVAX's resultant adaptation, the COVAX vaccines allocation mechanism will evolve into a Phase 2, which incorporates four main shifts in approach: 

• Allocation to be mainly driven by participant demand as supply constraints ease, with countries able to submit demand with supply allocated in response; 
• Account for all sources of supply to establish country population coverage and enhance equity; 
• Long-term rolling allocations and ranges to reflect uncertainty on the demand and supply side;  
• A more predictable and regular process for collection of demand information from participants. 

The explainer outlines the shifts in approach from Phase 1, rationale, allocation design (principles, objectives and steps) and governance considerations.